申请人:McDaniel Keith F.
                            
                            
                                公开号:US20100168384A1
                            
                            
                                公开(公告)日:2010-07-01
                            
                            Compounds capable of inhibiting replication of the hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
                            本发明描述了一种能够抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及制造此类化合物的方法,含有此类化合物的组合物以及使用此类化合物治疗HCV感染的方法。